Skip to main content
. 2021 Nov 3;54(7):1673–1680. doi: 10.1007/s11255-021-03048-6

Table 1.

Baseline characteristics and follow-up differences by estimated glomerular filtration rate (eGFR)

Total Low eGFR (< 60)a Normal eGFR (60 to 97)a Mild RHF (97 to 99.96)a, b Moderate RHF (99.96 to 102.44)a, b Extreme RHF (≥ 102.44)a, b Statistical test (all subgroups, n = 1187)c Statistical test (RHF subgroups, n = 269)c, d
n 1187 22 896 90 92 87
Deaths (column %) 826 (69.59) 14 (63.64) 597 (66.63) 74 (82.22) 67 (72.83) 74 (85.06) Chi-square: df = 4, X2 = 21.16, p < 0.001 Chi-square: df = 2, X2 = 4.61, p = 0.1
Age in years 54.42 [54.33, 54.50] 54.50 [54.33, 54.77] 54.42 [54.33, 54.50] 54.33 [54.17, 54.50] 54.33 [54.31, 54.42] 54.33 [54.33, 54.50] Kruskal–Wallis: df = 4, H = 20.62, p < 0.001 Kruskal–Wallis: df = 2, H = 1.35, p = 0.51
BMI (column %) Chi-square: dfe = NA, X2 = 27.08, p = 0.041 Chi-square: df = 8, X2 = 12.12, p = 0.146
 ≤ 25 373 (31.42) 6 (27.27) 266 (29.69) 26 (28.89) 37 (40.22) 38 (43.68)
 (25, 27.5] 365 (30.75) 9 (40.91) 276 (30.80) 27 (30.00) 25 (27.17) 28 (32.18)
 (27.5, 30] 253 (21.31) 3 (13.64) 209 (23.33) 20 (22.22) 12 (13.04) 9 (10.34)
 (30, 32.5] 126 (10.61) 4 (18.18) 95 (10.60) 11 (12.22) 12 (13.04) 4 (4.60)
 > 32.5 70 (5.90) 0 (0.00) 50 (5.58) 6 (6.67) 6 (6.52) 8 (9.20)
Smoking status (column %) Chi-square: df = 8, X2 = 32.22, p < 0.001 Chi-square: df = 4, X2 = 8.99, p = 0.061
 Never smoker 348 (29.32) 9 (40.91) 284 (31.70) 25 (27.78) 19 (20.65) 11 (12.64)
 Previous smoker 430 (36.23) 9 (40.91) 329 (36.72) 33 (36.67) 31 (33.70) 28 (32.18)
 Current smoker 409 (34.46) 4 (18.18) 283 (31.58) 32 (35.56) 42 (45.65) 48 (55.17)
 Alcohol consumption in g/week 40.80 [11.80, 96.68] 18.62 [5.43, 66.03] 38.45 [11.93, 94.95] 45.40 [14.48, 104.81] 48.00 [10.00, 103.69] 51.00 [11.50, 108.15] Kruskal–Wallis: df = 4, H = 4.76, p = 0.313 Kruskal–Wallis: df = 2, H = 0.51, p = 0.774
Hypertension (column %) 727 (61.25) 15 (68.18) 559 (62.39) 52 (57.78) 53 (57.61) 48 (55.17) Chi-square: df = 4, X2 = 3.26, p = 0.515 Chi-square: df = 2, X2 = 0.15, p = 0.926
Vitamin D deficiency (column %) 119 (10.03) 1 (4.55) 80 (8.93) 7 (7.78) 13 (14.13) 18 (20.69) Chi-square: dfe = NA, X2 = 15.12, p = 0.006 Chi-square: df = 2, X2 = 6.08, p = 0.048
eGFR in mL/min/1.73 m2 85.17 [76.98, 96.83] 56.65 [50.40, 58.65] 81.95 [75.22, 88.57] 99.13 [98.57, 99.60] 100.80 [100.74, 101.92] 104.88 [103.64, 107.24] Kruskal–Wallis: df = 4, H = 674.40, p < 0.001 Kruskal–Wallis: df = 2, H = 238.47, < 0.001
Follow-up in years 27.42 [18.06, 32.03] 26.23 [9.17, 30.01] 28.54 [19.73, 32.48] 23.68 [14.97, 30.25] 25.66 [16.41, 32.41] 20.84 [10.33, 28.47] Kruskal–Wallis: df = 4, H = 37.47, p < 0.001 Kruskal–Wallis: df = 2, H = 8.41, p = 0.015
Age of death in years 81.82 [72.44, 86.25] 80.61 [63.52, 84.70] 83.03 [74.05, 86.85] 77.97 [69.39, 84.61] 79.95 [70.87, 86.79] 75.17 [64.95, 82.96] Kruskal–Wallis: df = 4, H = 38.07, p < 0.001 Kruskal–Wallis: df = 2, H = 8.27, p = 0.016

Numbers indicate median [interquartile range] unless otherwise indicated

BMI body mass index in kg/m2, eGFR estimated glomerular filtration rate, RHF renal hyperfiltration

aIn mL/min/1.73 m2

bRHF subgroups were determined by cutoffs at 33.33 and 66.66 percentiles of men with RHF

cKruskal–Wallis rank-sum test and Pearson’s chi-squared test were used for across groups comparisons

dValues concern RHF subgroups only: mild RHF, moderate RHF, and extreme RHF

eBecause of the low expected frequencies in some cells, Monte-Carlo simulation (based on 5 × 105 replicates) was used to estimate p-value